Please try another search
By Samuel Indyk Investing.com – Novacyt (LON:NCYT) recorded a loss in the first half of the financial year as the contract dispute with the UK Department of Health and Social Care...
By Samuel Indyk Investing.com – Novacyt (LON:NCYT) has today announced the proposed accounting treatment of its ongoing dispute with the UK Department of Health and Social Care...
By Samuel Indyk Investing.com – AIM-listed Novacyt has announced that its SNPsig Covid-19 polymerase chain reaction (PCR) portfolio has been included in the NHS England...
BPOil major BP PLC (LON:BP) reported earnings on Tuesday where the company announced a $5.7bln loss in 2020. The FTSE 100 component saw its shares open the week at 274.25p which...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Sell | Strong Sell |
Technical Indicators | BUY | BUY | Strong Buy | Strong Sell | Strong Sell |
Summary | Buy | Buy | Strong Buy | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Bullish Engulfing | 1D | 5 | Mar 21, 2024 | ||
Three Outside Up | 1M | 7 | Aug 23 | ||
Engulfing Bearish | 1D | 7 | Mar 19, 2024 | ||
Bullish Engulfing | 30 | 7 | Mar 28, 2024 11:00 | ||
Downside Gap Three Methods | 1M | 8 | Jul 23 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
Paris | 0.5170 | 0.0000 | 0.0000 | 108,252 | +0.39% | EUR | |||
London | 44.60 | 43.00 | 46.40 | 51,362 | +0.79% | GBP |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
IAG | 176.75 | 177.70 | 170.95 | +5.25 | +3.06% | 34.56M | 16:35:59 | ||
Rolls-Royce Holdings | 426.70 | 430.50 | 411.40 | +4.70 | +1.11% | 16.81M | 16:35:59 | ||
Lloyds Banking | 51.76 | 52.54 | 51.57 | +0.09 | +0.17% | 157.24M | 16:35:59 | ||
Barclays | 183.20 | 185.74 | 182.82 | +1.68 | +0.93% | 48.73M | 16:35:59 | ||
Vodafone Group PLC | 70.460 | 70.720 | 69.700 | +1.040 | +1.50% | 65.30M | 16:35:59 | ||
Avacta Group | 49.75 | 50.00 | 48.40 | +0.75 | +1.53% | 3.37M | 16:35:59 | ||
M&G | 220.50 | 233.55 | 219.80 | -14.30 | -6.09% | 9.42M | 16:35:59 | ||
HSBC | 619.00 | 627.50 | 618.00 | +4.00 | +0.65% | 19.68M | 16:35:59 | ||
BP | 495.70 | 498.75 | 493.30 | +2.90 | +0.59% | 27.08M | 16:35:59 | ||
Carnival | 1,169.5 | 1,236.5 | 1,169.5 | -67.0 | -5.42% | 959.11K | 16:35:59 |
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review